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CIRCULATING levels and role of IL-6, IL-1ra, TNFsr-II
and CRP in patients with heatstroke is not fully
known. This study correlated levels of these
mediators with outcome in 26 patients. In survi-
vors (n 20), IL-6 concentration declined on
cooling, whereas in non-survivors levels contin-
ued to increase at 6 h following admission before
declining. Admission TNFsr-II concentrations in
survivors were signi￿ cantly lower than non-survi-
vors and levels continued to rise in both groups.
IL-1ra levels were markedly elevated in both
groups. Changes in cytokine levels were not in￿ u-
enced by renal function. Elevated C-reactive pro-
tein levels were observed for both groups and
remained so despite cooling, furthermore, there
was no correlation with alanine aminotransferase
levels. The study demonstrated the elevation of
the above mediators and suggested a role in the
pathogenesis of heatstroke. Markedly elevated
levels or those that remained elevated despite
cooling were associated with mortality.
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Introduction
Heatstroke, a true medical emergency, occurs in
two distinct settings exertional hyperthermia
during hot humid weather, and that due to
impaired heat dissipation, mostly seen in seden-
tary and elderly persons.1
Patients with heatstroke have complete loss
of thermoregulation, present with core body
temperature . 408 C, hot dry skin, neurological
dysfunction with impaired mental status and
occasionally coma.2 Mortality rate is high where
terminal events include shock, arrhythmias,
myocardial infarction, renal failure and various
neurological dysfunctions.3
Cytokines play a major role, both in heat
production and in modulating the response to
stress and trauma. Interleukin-6 (IL-6), a pleio-
tropic cytokine, modulates the acute phase
response and stimulates hepatic synthesis and
release of C-reactive protein (CRP).4 Other
mediators of acute phase response include:
tumour necrosis factor alpha (TNFa) and inter-
leukin-1 (IL-1), both modulate the release and
activity of IL-6.5 The activities of TNFa and IL-1
are attenuated by circulating inhibitors namely
TNF soluble receptors (TNFsr) I and II6,7 and IL-
1 receptor antagonist (IL-1ra) respectively.8
These inhibitors may afford a protective me-
chanism against a continued in￿ammatory pro-
cess.
Elevated TNFsr-II levels have been observed
in various pathological conditions including
endotoxaemia and infection9,10 and several re-
ports showed correlation between concentra-
tions of TNFand its soluble receptor.11
IL-1ra is released under various conditions
such as trauma and in￿ammation.12,13
Hepatocytes play a major role in acute phase
response. The effect of the heatstroke on
hepatocytes and thus on the synthesis and
release of CRP and cytokines was assessed by
measuring circulating alanine aminotransferase
(ALT) levels. Furthermore, the effect of possible
renal dysfunction in heatstroke on the circulat-
ing levels of these cytokines was assessed by
correlating with serum creatinine levels.
The circulating levels and role of these
protein mediators in hyperthermia and in the
pathogenesis and outcome of heatstroke is
unknown. In this study, we measured serum
concentrations of stimulators/mediators of the
acute phase response (IL-6 and CRP) and
inhibitors/neutralizers of cytokine activities
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during pilgrimage to Makkah and correlated the
circulating levels with outcome.
Materials and Methods
IL-6, IL-1ra, and TNFsr-II enzyme-linked immuno-
sorbent assay (ELISA) kits were obtained from
R&D Systems Europe, Abingdon, Oxfordshire,
UK. Analysis was performed according to the
supplier’s instructions. CRP , creatinine, and ALT
assay kits were obtained from Boehringer Mann-
heim (BM), Hertfordshire, UK, and analysis
performed on a Hitachi 911 analyser (BM)
according to the supplier’s instructions.
Subjects
Blood samples (n 86) were obtained from 26
patients (eight males) admitted to the heat-
stroke centre during the 1994 pilgrimage to
Makkah. Patients’ ages ranged from 30 to 75
years (median 60 years). Patients were classi￿ed
as suffering from heatstroke if presented with:
core body temperature . 40 58 C, hot dry skin
and impaired mental status. Ethical committee
approval was obtained and blood samples were
collected at 0, 6, 12 and 24 h following admis-
sion. Serum was collected by centrifugation and
analysed for creatinine and ALT levels. Aliquots
were stored at 708 C until transport on dry ice
to Liverpool, UK, where cytokines and CRP
measurements were performed.
Results
Patients’ core body temperatures ranged from
408 C to 43 28 C (median 42 38 C). Patients were
cooled to 388 C using conventional cooling bed
(lukewarm water spray and cool moving air).
Cooling took 45 to 180min (median 120min).
Six patients (three males, three females) died
giving a mortality rate of 23% .
Biochemical parameters measured were not
normally distributed (Royston’s development of
the Shapiro-Francia W test).14 A non-parametric
Wilcoxon rank sum test was therefore used to
determine statistical signi￿cance and results are
expressedas medianandrange (T ables 1and2).
IL-6
IL-6 was detected in all samples with values
ranging from 4 to 1594 pg ml (median 195). IL-
6 levels at admission were markedly elevated in
all patients. There was no signi￿cant difference
in median IL-6 admission values between survi-
vors and non-survivors (Table 1). IL-6 levels
declined on cooling (0 8 pg ml min) over the
￿rst 6 h in survivors. By contrast, in non-
survivors serum concentrations of IL-6 contin-
ued to increase 6 h following admission before
declining (T able 1).
There was no correlation between cooling
time and IL-6 levels at admission (r2 0 03).
Additionally, there was no correlation between
IL-6 levels at 0 and 6 h following admission and
core body temperature (r2 0 03 and 0.2
respectively).
Table 1. Showing median and range values for serum IL-6, TNFsr-II, IL-1ra and CRP concentrations in patients with
heatstroke at admission, 6, 12 and 24 h following admission. S: survivors (n 20); NS: non-survivors (n 6)
Time (h)
0 6 12 24
IL-6 (pg ml) S 479 113 51 63
32± 1177 6± 1338 4± 775 5± 512
NS 890 1411 608 436(n 2)
89± 1326 271± 1594 282± 934 129± 743
p 0.14 p , 0.01 p , 0.06 ±
TFNsr-II (pg ml) S 307 393 429 522
175± 547 221± 711 241± 904 360± 1119
NS 526 536 725 (n 2) 1040 (n 1)
347± 671 368± 722 638± 812 ±
p , 0.005 p 0.19 ± ±
IL-1ra (pg ml) S . 1888 . 7573 . 7573 . 3117
215± . 7573 1027± . 7573 810± . 7573 722± . 7573
NS . 5085 . 7573 . 7573 . 7573 (n 1)
200± . 7573 . 7573± . 7573 . 7573± . 7573 ±
CRP (ml l) S 4.9 6.3 11.2 20.1
, 1± 43.5 , 1± 42.7 , 1± 64.4 10.7± 138.8
NS 19.3 8.6 14.9 26.5
, 1± 65.1 1± 55.1 1.7± 28.0 (n 2) 35.8 (n 1)
p 0.31 p 0.74 ± ±
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tween IL-6 and creatinine levels at admission
(r2 0 16), 6 h (r2 0 4), and 12 h (r2 0 45),
whereas the correlation at 24 h was poor
(r2 0 64). However, in non-survivors no corre-
lation was observed between IL-6 and creatinine
at admission (r2 0 31) whereas the correlation
at 6 h was poor (r2 0 56).
TNFsr-II
TNFsr-II was detected in all samples. On ad-
mission, non-survivors showed signi￿cantly
(p , 0 005) higher concentrations than survi-
vors (Table 1). Furthermore, despite cooling,
concentrations in both groups continued to rise
following admission. The degree of rise was,
however, greater in non-survivors compared
with survivors (T able 1).
In survivors, there was no correlation be-
tween TNFsr-II and creatinine levels at admis-
sion (r2 0 0) and 6 h (r2 0 44), whereas,
the correlation was positive at 12 and 24 h
following admission (r2 0 69, and 0.76 re-
spectively). In non-survivors, there was no
correlation between TNFsr-II and creatinine
levels at admission or 6 h following admission
(r2 0 22, and 0.3 respectively).
IL-1ra
Markedly elevated IL-1ra concentrations were
detected in all samples. The serum concentra-
tions increased markedly following admission in
both groups reaching levels above the upper
limit of the assay (7573 ng ml). Among survi-
vors, the serum concentration in some patients
fell between 12 and 24 h following admission,
but remained markedly elevated (T able 1).
CRP
Circulating CRP concentrations ranged between
non-detectable (, 1 ml l) and 138 8 mg l (me-
dian 8.7). Levels continued to rise in both
survivors and non-survivors, however, there was
no signi￿cant difference between both groups
at all times (T able 1). There was no correlation
between peak CRP levels and admission IL-6
concentrations (r2 0 02).
There was no correlation between ALT and
CRP levels at admission (r2 0 2), however,
poor positive correlation was observed 6 h
following admission (r2 0 52).
Creatinine
Serum creatinine levels ranged from 37 to
384 mmol l (median 115) in survivors, whereas
in non-survivors the levels ranged from 63 to
328 mmol l (median 189). Median creatinine
levels at all times in both groups were above
the upper limit of normal (97 mmol l) (Table 2).
There was no signi￿cant difference (p . 0 2)
between creatinine levels in survivors at all
times, and between 0 and 6 h in non-survivors.
How-ever, signi￿cant difference was found be-
tween survivors and non-survivors 6 h follow-
ing admission with higher levels in the latter
(Table 2).
ALT
Circulating ALT levels ranged from non-detect-
able to 469 IU l (median 26) in survivors and
between 11 and 136 (median 45.5) in non-
survivors. Seventy-￿ve per cent of all patients
had ALT level below the upper limit of normal
(43 IU l).
In survivors, levels increased following admis-
sion with signi￿cant difference between 0 and
Table 2. Showing median and range values for serum creatinine and ALT levels in
patients with heatstroke at admission, 6, 12 and 24 h following admission. S:
survivors (n 20); NS: non-survivors (n 6)
Time (h)
0 6 12 2
Creatinine S 142 139 100 102
(mmol/l) 58± 265 62± 285 37± 332 50± 384
NS 167 234 n 2 328(n 1)
63± 226 146± 307 169± 215 ±
p 0.6 p , 0.002 ± ±
ALT (IU/l) S 14 26 30 41
0± 235 6± 469 4± 372 11± 253
NS 23 53 n 2 136(n 1)
11± 63 34± 114 35± 118 ±
p 0.1 p , 0.002 ± ±
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(p , 0 002), but no signi￿cant difference be-
tween 6 and 12 h and between 12 and 24 h
(p 0 5). In non-survivors no signi￿cant differ-
ence was found at 0 and 6 h following admis-
sion. However, the difference between both
groups was signi￿cant only at 6 h following
admission (Table 2).
Discussion
This study examined the changes in serum of
patients with heatstroke of the acute phase
reactant ‘C-reactive protein’, the major mediator
cytokine IL-6, and that of the inhibitors/modula-
tors of the in￿ammatory response namely IL-1ra
and TNFsr-II.
IL-6, IL-1ra, TNFsr-II were detected in all
samples, the general pattern being of markedly
elevated levels at admission which either de-
clined or continued to increase following cool-
ing.
Although survivors had elevated IL-6 levels,
concentrations greater than 900 pg ml at admis-
sion or those which continued to rise were
associated with mortality. This ￿nding is analo-
gous to that observed in septic patients where
levels greater than 950 pg ml were associated
with increased mortality.15 The presence of high
IL-6 concentrations in heatstroke patients have
previously been reported.16 The ￿ndings indi-
cate a possible role for IL-6 in the pathogenesis
of heatstroke and of uncontrolled body tem-
perature elevations. Although IL-6 has been
suggested to play a role in fever production,17
we found no correlation between IL-6 concen-
trations at admission and core body temperature
or cooling time. However, cooling was asso-
ciated with declining IL-6 levels. This ￿nding
suggests a possible role of other factors or
cytokines, either working independently or in
association with IL-6.
In our patients, IL-1ra and TNFsr-II were
markedly elevated at admission and whereas IL-
1ra in some patients, ￿nally, declined on cool-
ing, TNFsr-II continued to increase throughout
the study period.
IL-1ra inhibits IL-1 activity and thus limits the
in￿ammatory response mediated by IL-1.12 Mark-
edly elevated levels were observed in all pa-
tients (T able 1). However, in most samples,
levels were above the upper limit of the assay
and unfortunately, sample shortage did not
allow for repeat measurement and thus limited
statistical analysis of data. The markedly ele-
vated IL-1ra may re￿ect continued IL-1 release
or deranged IL-1ra production in excess of
requirement.
In this study, the pattern of circulating TNFsr-
II was in contrast to that seen for IL-6, where
survivors showed markedly elevated levels com-
pared with non-survivors. Furthermore, the
levels continued to rise despite cooling in both
groups. The degree of rise was greater in non-
survivors compared with survivors.
TNFsr-II inhibits TNFa activity and thus mod-
ulates its in￿ammatory action. TNFa levels has
been shown18 to be elevated in heatstroke
patients whereas levels decreased following
cooling and there was no correlation between
body temperature and TNFa. In our study,
markedly elevated TNFsr-II levels were observed
in both survivors and non-survivors, however,
signi￿cantly higher levels were associated with
mortality (Table 1).
CRP levels increased in all patients and
continued to rise despite cooling indicating
sustained release by hepatocytes. There was no
signi￿cant difference between median CRP
levels in both survivors and non-survivors. The
lack of correlation between admission IL-6 and
peak CRP levels suggests a possible role for
other mediators.
The possibility that cytokine levels were in￿u-
enced by renal function, known to be compro-
mised in these patients,3 was examined.
Cytokine levels were correlated with serum
creatinine as a re￿ection of renal function. In
non-survivors there was no or poor correlation
between creatinine and IL-6 and TNFsr-II levels.
Furthermore, in survivors there was no correla-
tion between IL-6, IL-1ra or TNFsr-II and creati-
nine levels at 0 and 6 h following admission and
poor positive correlation at later times. Since
the signi￿cant differences in cytokine levels
between survivors and non-survivors were only
observed early at 0 and 6 h following admission,
the lack of correlation with creatinine at these
times indicates that such differences were not
in￿uenced by renal function.
There was no correlation between CRP and
ALT levels at admission (r2 0 2), however the
correlation at 6 h was poor (r2 0 52) but
signi￿cant. Possible hepatic dysfunction sug-
gested by elevated ALT levels at 6 h following
admission did not signi￿cantly in￿uence CRP
levels. However, skeletal muscle also contain
signi￿cant amount of ALT and it is dif￿cult to
ascertain the source of the enzyme, further-
more, sample shortage did not allow for iso-
enzyme studies.
The mortality rate in our study was higher
than previously reported.3 This may be due to
the small sample size or to our patients’
settings.
It is known that the ability to eliminate heat
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clothing, that prevents sweating and evapora-
tive heat loss. Our patients may have exhibited
both heatstroke settings; exertional hyperther-
mia during hot humid weather and impaired
heat dissipation. The majority (69% ) of our
patients were females, and this may be a
consequence of dark-coloured, heavier and all-
covered-up clothing compared with white-co-
loured, lighter, relatively exposed clothing in
males. Physiological and psychological adapta-
tion to a hot environment can improve heat
tolerance,19 however this was not assessed in
this study.
In conclusion, it is clear that circulating levels
of IL-6, TNFsr-II, IL-1ra and CRP are signi￿cantly
elevated in sera from patients with heatstroke.
Cytokine concentrations that were markedly
elevated at admission or continued to increased
despite cooling were associated with poor out-
come. Signi￿cant changes in cytokine levels
between survivors and non-survivors were not
in￿uenced by renal or hepatic dysfunction.
Further studies are required in a larger group of
patients to examine the role of these mediators
in the pathogenesis of heatstroke and the
effects of different treatments on the circulating
cytokine levels and outcome.
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